Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct 21;12(10):3076.
doi: 10.3390/cancers12103076.

The Tumor Microenvironment of Pancreatic Cancer

Eva Karamitopoulou  1
Affiliations
Editorial

The Tumor Microenvironment of Pancreatic Cancer

Eva Karamitopoulou. Cancers (Basel). .

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis along with rising incidence rates and will be responsible for many cancer deaths in the future [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
(A): Pancreatic cancer from a long-term survivor (i.e., overall survival >60 months) with a «hot» tumor microenvironment, dominated by CD8+ cytotoxic tumor infiltrating lymphocytes (multiplex immunofluorescence ×400); (B): pancreatic cancer from a short-term survivor (overall survival <12 months) with an immunosuppressive tumor microenvironment poor in CD68+ tumor infiltrating lymphocytes and dominated by CD68+ tumor associated macrophages and FOXP3+ T regulatory cells (multiplex immunofluorescence ×400).
See this image and copyright information in PMC

References

    1. Kamisawa T., Wood L.D., Itoi T., Takaori K. Pancreatic cancer. Lancet. 2016;388:73–85. doi: 10.1016/S0140-6736(16)00141-0. - DOI - PubMed
    1. Rahib L., Smith B.D., Aizenberg R., Rosenzweig A.B., Fleshman J.M., Matrisian L.M. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. doi: 10.1158/0008-5472.CAN-14-0155. - DOI - PubMed
    1. Ryan D.P., Hong T.S., Bardeesy N. Pancreatic adenocarcinoma. N. Engl. J. Med. 2014;371:2140–2141. doi: 10.1056/NEJMra1404198. - DOI - PubMed
    1. Serrano P.E., Cleary S.P., Dhani N., Kim P.T., Greig P.D., Leung K., Moulton C.A., Gallinger S., Wei A.C. Improved long-term outcomes after resection of pancreatic adenocarcinoma: A comparison between two time periods. Ann. Surg. Oncol. 2015;22:1160–1167. doi: 10.1245/s10434-014-4196-2. - DOI - PubMed
    1. Bahra M., Pratschke J., Klein F., Neuhaus P., Boas-Knoop S., Puhl G., Denecke T., Pullankavumkal J.R., Sinn M., Riess H., et al. Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy. Pancreas. 2015;44:930–936. doi: 10.1097/MPA.0000000000000365. - DOI - PubMed

Publication types

LinkOut - more resources